宫腔手术后透明质酸凝胶对宫腔粘连与生育力的疗效及安全性:随机对照试验的系统评价与Meta分析及试验序贯分析
该系统评价与Meta分析纳入16项随机对照试验共2359例患者,评估宫腔手术后使用透明质酸凝胶对宫腔粘连和生育结局的影响。结果显示透明质酸降低宫腔粘连发生率(RR 0.53,95%CI 0.42-0.67,I²=48%)并提高妊娠率(RR 1.24,95%CI 1.02-1.50,I²=0%)。试验序贯分析提示对轻度宫腔粘连、妊娠率、活产率和流产率的影响可能不确定,需进一步临床试验评估。
要点
- 宫腔手术后使用透明质酸可降低宫腔粘连发生率(RR 0.53,95%CI 0.42-0.67)。
- 透明质酸可提高妊娠率(RR 1.24,95%CI 1.02-1.50),但试验序贯分析提示该结果可能不确定。
- 小体积透明质酸可降低宫腔粘连发生率,随访6至12周后保护效应有统计学意义。
核心结论
- 透明质酸可安全有效地降低宫腔粘连发生率,并可能改善生育结局。
研究设计与样本
- 系统评价与Meta分析及试验序贯分析,检索PubMed、EMBASE、Cochrane Library、Web of Science和ClinicalTrials.gov至2023年11月1日。
- 纳入16项报告宫腔手术后使用透明质酸的宫腔粘连和生育结局的随机对照试验,共2359例患者。
- 采用Cochrane手册标准评估偏倚风险,使用推荐分级的评估、制定与评价(GRADE)系统评价证据质量,遵循系统评价和Meta分析优先报告条目(PRISMA)指南。
- 使用Stata 14进行敏感性分析和发表偏倚分析。
主要发现
- 透明质酸降低宫腔粘连发生率(RR 0.53,95%CI 0.42-0.67,I²=48%)。
- 透明质酸提高妊娠率(RR 1.24,95%CI 1.02-1.50,I²=0%)。
- 亚组分析发现小体积透明质酸可降低宫腔粘连发生率。
- 透明质酸在接受各种宫腔手术及具有不同妇科病史的患者中均表现出保护效应。
- 随访6至12周后保护效应有统计学意义。
关键数值与推荐
- 宫腔粘连发生率:RR 0.53(95%CI 0.42-0.67,I²=48%)。
- 妊娠率:RR 1.24(95%CI 1.02-1.50,I²=0%)。
- 试验序贯分析提示透明质酸对轻度宫腔粘连发生率、妊娠率、活产率和流产率的影响可能不确定,需进一步临床试验评估;其余效应可验证,无需更多临床试验确认。
临床怎么用
- 原文未据此给出推荐。
局限性
- 试验序贯分析提示透明质酸对轻度宫腔粘连发生率、妊娠率、活产率和流产率的影响可能不确定,需进一步临床试验评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to determine the efficacy and safety of hyaluronic acid gel for the prevention of intrauterine adhesions and improved fertility after intrauterine surgery. DATA SOURCES: PubMed, EMBASE, Cochrane Library, Web of science, and ClinicalTrials.gov were searched up to November 1, 2023. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials that reported intrauterine adhesion and fertility outcomes among women who used hyaluronic acid after intrauterine surgery. METHODS: The risk of bias was assessed using criteria of the Cochrane Handbook, and the quality of the evidence was evaluated using the Grades of Recommendation, Assessment, Development, and Evaluation system. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. A trial sequential analysis was conducted to assess the outcomes, and Stata 14 was used for sensitivity analyses and publication bias analyses. RESULTS: Data from 16 randomized controlled trials involving 2359 patients were extracted and analyzed. The analysis revealed that hyaluronic acid reduced the incidence of intrauterine adhesion (risk ratio, 0.53; 95% confidence interval, 0.42-0.67; I2=48%) and improve pregnancy rates (risk ratio, 1.24; 95% confidence interval, 1.02-1.50; I2=0%). A subgroup analysis was conducted to evaluate factors that influence the effect of hyaluronic acid on the incidence of intrauterine adhesion. It was found that a small volume of hyaluronic acid reduced the incidence of intrauterine adhesions. Hyaluronic acid exhibited a protective effect among patients who underwent various intrauterine surgeries and who had different gynecologic medical histories. The protective effect was statistically significant after a follow-up of 6 to 12 weeks. The results of the trial sequential analysis indicated that the effect of hyaluronic acid on the incidence of mild intrauterine adhesions, pregnancy rates, live birth rates, and miscarriage rates after intrauterine surgery may be inconclusive and thus further evaluation is required in the form of additional clinical trials. However, the remaining effects were found to be verifiable and did not require more clinical trials for confirmation. CONCLUSION: Hyaluronic acid can safely and effectively reduce the incidence of intrauterine adhesions and may improve fertility outcomes.
引用
- Luo Y, Sun Y, Huang B, et al. Effects and safety of hyaluronic acid gel on intrauterine adhesion and fertility after intrauterine surgery: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Am J Obstet Gynecol. 2024. PMID: 38191020. doi:10.1016/j.ajog.2023.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。